This reduction in contractile performance was significantly attenuated by both the ACE inhibitor Enalapril and the AT1R antagonist Losartan treatment (T1D + Ena and T1D + Los groups). The gene discussed is AGTR1; the disease is type 1 diabetes mellitus.